دورية أكاديمية

A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements.

التفاصيل البيبلوغرافية
العنوان: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements.
المؤلفون: Kimmerling, Robert J., Stevens, Mark M., Olcum, Selim, Minnah, Anthony, Vacha, Madeleine, LaBella, Rachel, Ferri, Matthew, Wasserman, Steven C., Fujii, Juanita, Shaheen, Zayna, Sundaresan, Srividya, Ribadeneyra, Drew, Jayabalan, David S., Agte, Sarita, Aleman, Adolfo, Criscitiello, Joseph A., Niesvizky, Ruben, Luskin, Marlise R., Parekh, Samir, Rosenbaum, Cara A.
المصدر: Communications Biology; 11/26/2022, Vol. 5 Issue 1, p1-14, 14p
مصطلحات موضوعية: MASS measurement, ANTINEOPLASTIC agents, PHARMACOGENOMICS, DRUG utilization, DRUG efficacy, ECULIZUMAB, MACHINE learning
مستخلص: Functional precision medicine offers a promising complement to genomics-based cancer therapy guidance by testing drug efficacy directly on a patient's tumor cells. Here, we describe a workflow that utilizes single-cell mass measurements with inline brightfield imaging and machine-learning based image classification to broaden the clinical utility of such functional testing for cancer. Using these image-curated mass measurements, we characterize mass response signals for 60 different drugs with various mechanisms of action across twelve different cell types, demonstrating an improved ability to detect response for several slow acting drugs as compared with standard cell viability assays. Furthermore, we use this workflow to assess drug responses for various primary tumor specimen formats including blood, bone marrow, fine needle aspirates (FNA), and malignant fluids, all with reports generated within two days and with results consistent with patient clinical responses. The combination of high-resolution measurement, broad drug and malignancy applicability, and rapid return of results offered by this workflow suggests that it is well-suited to performing clinically relevant functional assessment of cancer drug response. A pipeline for drug sensitivity testing using cell mass from sample collection to data analysis is presented. [ABSTRACT FROM AUTHOR]
Copyright of Communications Biology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:23993642
DOI:10.1038/s42003-022-04270-3